Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 10.24
(0.29%)
CNY 10.24
(0.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 130.06 Million CNY | -23.28% |
| 2022 | 157.46 Million CNY | 2.3% |
| 2021 | 160.3 Million CNY | 45.8% |
| 2020 | 108.3 Million CNY | 0.51% |
| 2019 | 107.84 Million CNY | 7.49% |
| 2018 | 99.3 Million CNY | 18.91% |
| 2017 | 89.59 Million CNY | -4.83% |
| 2016 | 79.26 Million CNY | 26.47% |
| 2015 | 65.38 Million CNY | 26.98% |
| 2014 | 52.97 Million CNY | 81.22% |
| 2013 | 32.32 Million CNY | -22.48% |
| 2012 | 40.35 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 23.2 Million CNY | 801.71% |
| 2024 Q2 | 28.3 Million CNY | 39.76% |
| 2024 Q3 | 39.04 Million CNY | 8.3% |
| 2023 FY | - CNY | -23.28% |
| 2023 Q2 | 35.56 Million CNY | 17.29% |
| 2023 Q3 | 52.11 Million CNY | 46.54% |
| 2023 Q4 | -16.43 Million CNY | -131.54% |
| 2023 Q1 | 30.31 Million CNY | 245.24% |
| 2022 Q3 | 55.03 Million CNY | 58.0% |
| 2022 Q2 | 34.83 Million CNY | -10.03% |
| 2022 Q1 | 38.71 Million CNY | 95.58% |
| 2022 FY | - CNY | 2.3% |
| 2022 Q4 | 8.78 Million CNY | -84.04% |
| 2021 Q4 | 19.79 Million CNY | -60.52% |
| 2021 Q1 | 35.58 Million CNY | 170.15% |
| 2021 FY | - CNY | 45.8% |
| 2021 Q2 | 30.83 Million CNY | -13.34% |
| 2021 Q3 | 50.13 Million CNY | 62.57% |
| 2020 Q2 | 30.52 Million CNY | 1276.73% |
| 2020 Q3 | 44.15 Million CNY | 44.66% |
| 2020 FY | - CNY | 0.51% |
| 2020 Q1 | 2.21 Million CNY | 251.51% |
| 2020 Q4 | 13.17 Million CNY | -70.17% |
| 2019 Q3 | 49.75 Million CNY | 92.71% |
| 2019 Q2 | 25.81 Million CNY | 39.56% |
| 2019 Q1 | 18.49 Million CNY | 101.87% |
| 2019 FY | - CNY | 7.49% |
| 2019 Q4 | -1.46 Million CNY | -102.94% |
| 2018 Q4 | 9.16 Million CNY | -76.67% |
| 2018 Q1 | 20.23 Million CNY | 249.09% |
| 2018 FY | - CNY | 18.91% |
| 2018 Q2 | 18.79 Million CNY | -7.15% |
| 2018 Q3 | 39.28 Million CNY | 109.05% |
| 2017 Q1 | 21.14 Million CNY | 448.76% |
| 2017 FY | - CNY | -4.83% |
| 2017 Q4 | 5.79 Million CNY | -85.98% |
| 2017 Q3 | 41.35 Million CNY | 113.66% |
| 2017 Q2 | 19.35 Million CNY | -8.47% |
| 2016 FY | - CNY | 26.47% |
| 2016 Q2 | 20.37 Million CNY | -7.28% |
| 2016 Q3 | 35.65 Million CNY | 75.0% |
| 2016 Q1 | 21.97 Million CNY | 49.66% |
| 2016 Q4 | 3.85 Million CNY | -89.19% |
| 2015 Q4 | 14.68 Million CNY | 0.0% |
| 2015 Q2 | 18.39 Million CNY | 0.0% |
| 2015 Q1 | 18.39 Million CNY | 24.28% |
| 2015 FY | - CNY | 26.98% |
| 2015 Q3 | 14.68 Million CNY | -20.18% |
| 2014 Q1 | 11.37 Million CNY | 0.0% |
| 2014 Q2 | 11.37 Million CNY | -0.0% |
| 2014 FY | - CNY | 81.22% |
| 2014 Q3 | 14.8 Million CNY | 30.1% |
| 2014 Q4 | 14.8 Million CNY | 0.0% |
| 2013 FY | - CNY | -22.48% |
| 2012 FY | - CNY | 0.0% |